Sensorion Is A Clinical Stage Biotechnology Company Based In Montpellierfranceit Specializes In Developing Innovative Therapies For Inner Ear Disordersincluding Hearing Loss And Balance Issuesthe Company Was Founded To Meet The Medical Needs Associated With Auditory And Vestibular Pathologiesfocusing On Gene Therapy And Small Molecule Treatments Sensorion S Portfolio Includes Several Key Products And Programsthese Are Designed To Restoretreatand Prevent Inner Ear Disordersnotable Offerings Include Otof Gta Gene Therapy For Otoferlin Deficiencysens 401A Small Molecule Candidate For Sudden Sensorineural Hearing Loss And Cisplatin Induced Ototoxicityand Gene Therapies For Usher Syndrome Type 1 And Gjb2 Related Hearing Lossthe Company Also Emphasizes Preventive Therapies For Non Genetic Hearing Loss With A Proprietary R&D Platformsensorion Studies Inner Ear Pathophysiology To Enhance Drug Discovery And Gene Therapy Developmentthe Company Collaborates With Healthcare Providers And Researchers Worldwide To Advance Its Clinical Pipeline And Improve Patient Outcomes In Conditions Like Meniereae S Disease And Tinnitus
